The Asia Pacific Actinic Keratosis Treatment Market would witness market growth of 5.2% CAGR during the forecast period (2022-2028).
There are numerous actinic keratosis treatment methods nowadays. The most commonly employed methods include cryotherapy, excision, chemical peels, and photodynamic therapy. A chemical peel resembles a high-end face mask. During an office visit, the healthcare professional apply the peel. The treatment's ingredients safely remove any unwelcome skin growths from the epidermis. The treated region remains painful and red for the first few days.
Before beginning the excision procedure, the doctor numbs the area around the AK. The AKs are then removed surgically or by scraping, and the wound is stitched back up. The wound typically heals in two to three weeks. Photodynamic therapy may be suggested by the doctor if patients have several AKs or AKs that recur after treatment. In order to eliminate precancerous skin cells, this treatment employs lotions and specialized light therapy. While the treated skin heals, the patient will need to avoid the sun for a few days.
Additionally, the coronavirus disease pandemic of 2019 (COVID-19) had a significant impact on dermatology, as evidenced by the decrease in consultations and procedures, as well as the introduction of teledermatology (TD). During the pandemic, many dermatologists employed teledermatology.
Actinic keratosis cases have increased as a result of an increase in baldness, skin wrinkling, and sunburn patches. Compared to patients from other regions, those from New Zealand and Australia in particular, frequently displayed higher negative consequences of sun exposure since actinic keratosis is more common in nations that are closer to the equator. Australia has an actinic keratosis prevalence rate that is very close to half of its population due to its proximity to the equator.
The China market dominated the Asia Pacific Actinic Keratosis Treatment Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $607.9 Million by 2028.The Japan market is estimated to grow a CAGR of 4.5% during (2022 - 2028). Additionally, The India market would display a CAGR of 5.8% during (2022 - 2028).
Based on Drug Class, the market is segmented into Nucleoside Metabolic Inhibitor, NSAIDs, Immune Response Modifiers, Photoenhancers and Others. Based on Therapy, the market is segmented into Surgery, Topical and Photodynamic Therapy. Based on End-use, the market is segmented into Hospitals, Private Clinics, Homecare and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Actinic Keratosis Treatment Market is Projected to reach USD 8 Billion by 2028, at a CAGR of 4.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Almirall, S.A, LEO Pharma A/S, Biofrontera AG, Sun Pharmaceuticals Industries Ltd., 3M Company, Bausch Health Companies, Inc., Novartis AG, Viatris, Inc., and Galderma S.A.
Scope of the Study
Market Segments Covered in the Report:
By Drug Class
- Nucleoside Metabolic Inhibitor
- NSAIDs
- Immune Response Modifiers
- Photoenhancers
- Others
By Therapy
- Surgery
- Topical
- Photodynamic Therapy
By End-use
- Hospitals
- Private Clinics
- Homecare
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Almirall, S.A
- LEO Pharma A/S
- Biofrontera AG
- Sun Pharmaceuticals Industries Ltd.
- 3M Company
- Bausch Health Companies, Inc.
- Novartis AG
- Viatris, Inc.
- Galderma S.A.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Actinic Keratosis Treatment Market, by Drug Class
1.4.2 Asia Pacific Actinic Keratosis Treatment Market, by Therapy
1.4.3 Asia Pacific Actinic Keratosis Treatment Market, by End-use
1.4.4 Asia Pacific Actinic Keratosis Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Actinic Keratosis Treatment Market by Drug Class
3.1 Asia Pacific Nucleoside Metabolic Inhibitor Market by Country
3.2 Asia Pacific NSAIDs Market by Country
3.3 Asia Pacific Immune Response Modifiers Market by Country
3.4 Asia Pacific Photoenhancers Market by Country
3.5 Asia Pacific Others Market by Country
Chapter 4. Asia Pacific Actinic Keratosis Treatment Market by Therapy
4.1 Asia Pacific Surgery Market by Country
4.2 Asia Pacific Topical Market by Country
4.3 Asia Pacific Photodynamic Therapy Market by Country
Chapter 5. Asia Pacific Actinic Keratosis Treatment Market by End-use
5.1 Asia Pacific Hospitals Market by Country
5.2 Asia Pacific Private Clinics Market by Country
5.3 Asia Pacific Homecare Market by Country
5.4 Asia Pacific Others Market by Country
Chapter 6. Asia Pacific Actinic Keratosis Treatment Market by Country
6.1 China Actinic Keratosis Treatment Market
6.1.1 China Actinic Keratosis Treatment Market by Drug Class
6.1.2 China Actinic Keratosis Treatment Market by Therapy
6.1.3 China Actinic Keratosis Treatment Market by End-use
6.2 Japan Actinic Keratosis Treatment Market
6.2.1 Japan Actinic Keratosis Treatment Market by Drug Class
6.2.2 Japan Actinic Keratosis Treatment Market by Therapy
6.2.3 Japan Actinic Keratosis Treatment Market by End-use
6.3 India Actinic Keratosis Treatment Market
6.3.1 India Actinic Keratosis Treatment Market by Drug Class
6.3.2 India Actinic Keratosis Treatment Market by Therapy
6.3.3 India Actinic Keratosis Treatment Market by End-use
6.4 South Korea Actinic Keratosis Treatment Market
6.4.1 South Korea Actinic Keratosis Treatment Market by Drug Class
6.4.2 South Korea Actinic Keratosis Treatment Market by Therapy
6.4.3 South Korea Actinic Keratosis Treatment Market by End-use
6.5 Singapore Actinic Keratosis Treatment Market
6.5.1 Singapore Actinic Keratosis Treatment Market by Drug Class
6.5.2 Singapore Actinic Keratosis Treatment Market by Therapy
6.5.3 Singapore Actinic Keratosis Treatment Market by End-use
6.6 Malaysia Actinic Keratosis Treatment Market
6.6.1 Malaysia Actinic Keratosis Treatment Market by Drug Class
6.6.2 Malaysia Actinic Keratosis Treatment Market by Therapy
6.6.3 Malaysia Actinic Keratosis Treatment Market by End-use
6.7 Rest of Asia Pacific Actinic Keratosis Treatment Market
6.7.1 Rest of Asia Pacific Actinic Keratosis Treatment Market by Drug Class
6.7.2 Rest of Asia Pacific Actinic Keratosis Treatment Market by Therapy
6.7.3 Rest of Asia Pacific Actinic Keratosis Treatment Market by End-use
Chapter 7. Company Profiles
7.1 Almirall, S.A
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Product Launches and Product Expansions:
7.2 LEO Pharma A/S
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.3 Biofrontera AG
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Research & Development Expenses
7.4 Sun Pharmaceuticals Industries Ltd.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expenses
7.5 3M Company
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 SWOT Analysis
7.6 Bausch Health Companies, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.7 Novartis AG
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.8 Viatris, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Galderma S.A.
7.9.1 Company Overview
TABLE 1 Asia Pacific Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 3 Asia Pacific Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 4 Asia Pacific Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 5 Asia Pacific Nucleoside Metabolic Inhibitor Market by Country, 2018 - 2021, USD Million
TABLE 6 Asia Pacific Nucleoside Metabolic Inhibitor Market by Country, 2022 - 2028, USD Million
TABLE 7 Asia Pacific NSAIDs Market by Country, 2018 - 2021, USD Million
TABLE 8 Asia Pacific NSAIDs Market by Country, 2022 - 2028, USD Million
TABLE 9 Asia Pacific Immune Response Modifiers Market by Country, 2018 - 2021, USD Million
TABLE 10 Asia Pacific Immune Response Modifiers Market by Country, 2022 - 2028, USD Million
TABLE 11 Asia Pacific Photoenhancers Market by Country, 2018 - 2021, USD Million
TABLE 12 Asia Pacific Photoenhancers Market by Country, 2022 - 2028, USD Million
TABLE 13 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 14 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 15 Asia Pacific Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 16 Asia Pacific Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 17 Asia Pacific Surgery Market by Country, 2018 - 2021, USD Million
TABLE 18 Asia Pacific Surgery Market by Country, 2022 - 2028, USD Million
TABLE 19 Asia Pacific Topical Market by Country, 2018 - 2021, USD Million
TABLE 20 Asia Pacific Topical Market by Country, 2022 - 2028, USD Million
TABLE 21 Asia Pacific Photodynamic Therapy Market by Country, 2018 - 2021, USD Million
TABLE 22 Asia Pacific Photodynamic Therapy Market by Country, 2022 - 2028, USD Million
TABLE 23 Asia Pacific Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 24 Asia Pacific Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 25 Asia Pacific Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 26 Asia Pacific Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 27 Asia Pacific Private Clinics Market by Country, 2018 - 2021, USD Million
TABLE 28 Asia Pacific Private Clinics Market by Country, 2022 - 2028, USD Million
TABLE 29 Asia Pacific Homecare Market by Country, 2018 - 2021, USD Million
TABLE 30 Asia Pacific Homecare Market by Country, 2022 - 2028, USD Million
TABLE 31 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 32 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 33 Asia Pacific Actinic Keratosis Treatment Market by Country, 2018 - 2021, USD Million
TABLE 34 Asia Pacific Actinic Keratosis Treatment Market by Country, 2022 - 2028, USD Million
TABLE 35 China Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 36 China Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 37 China Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 38 China Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 39 China Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 40 China Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 41 China Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 42 China Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 43 Japan Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 44 Japan Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 45 Japan Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 46 Japan Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 47 Japan Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 48 Japan Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 49 Japan Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 50 Japan Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 51 India Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 52 India Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 53 India Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 54 India Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 55 India Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 56 India Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 57 India Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 58 India Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 59 South Korea Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 60 South Korea Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 61 South Korea Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 62 South Korea Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 63 South Korea Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 64 South Korea Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 65 South Korea Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 66 South Korea Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 67 Singapore Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 68 Singapore Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 69 Singapore Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 70 Singapore Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 71 Singapore Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 72 Singapore Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 73 Singapore Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 74 Singapore Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 75 Malaysia Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 76 Malaysia Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 77 Malaysia Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 78 Malaysia Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 79 Malaysia Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 80 Malaysia Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 81 Malaysia Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 82 Malaysia Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 83 Rest of Asia Pacific Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 84 Rest of Asia Pacific Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 85 Rest of Asia Pacific Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 86 Rest of Asia Pacific Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 87 Rest of Asia Pacific Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 88 Rest of Asia Pacific Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 89 Rest of Asia Pacific Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 90 Rest of Asia Pacific Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 91 Key Information – Almirall, S.A
TABLE 92 key information – LEO Pharma A/S
TABLE 93 Key Information – Biofrontera AG
TABLE 94 Key Information – Sun Pharmaceuticals Industries Ltd.
TABLE 95 Key Information – 3M Company
TABLE 96 key information – Bausch Health Companies, Inc.
TABLE 97 Key Information – Novartis AG
TABLE 98 key information – Viatris, Inc.
TABLE 99 Key Information – Galderma S.A.
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Almirall, S.A
FIG 3 SWOT Analysis: 3M Company